FI752211A - - Google Patents

Info

Publication number
FI752211A
FI752211A FI752211A FI752211A FI752211A FI 752211 A FI752211 A FI 752211A FI 752211 A FI752211 A FI 752211A FI 752211 A FI752211 A FI 752211A FI 752211 A FI752211 A FI 752211A
Authority
FI
Finland
Application number
FI752211A
Other languages
Finnish (fi)
Other versions
FI63229B (fi
FI63229C (fi
Inventor
Herbert Merz
Adolf Langbein
Gerhard Walther
Klaus Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI752211A publication Critical patent/FI752211A/fi
Publication of FI63229B publication Critical patent/FI63229B/fi
Application granted granted Critical
Publication of FI63229C publication Critical patent/FI63229C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI752211A 1974-08-05 1975-08-04 Foerfarande foer framstaellning av analgetiskt verkande racemiskt eller diastereomera och optiskt aktiva 2-tetrahydrofurfuryl-5,9 beta-dimetyl-6,7-bensomorfaner och deras syraadditionssalter FI63229C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2437610 1974-08-05
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
FI752211A true FI752211A (fr) 1976-02-06
FI63229B FI63229B (fi) 1983-01-31
FI63229C FI63229C (fi) 1983-05-10

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
FI752211A FI63229C (fi) 1974-08-05 1975-08-04 Foerfarande foer framstaellning av analgetiskt verkande racemiskt eller diastereomera och optiskt aktiva 2-tetrahydrofurfuryl-5,9 beta-dimetyl-6,7-bensomorfaner och deras syraadditionssalter

Country Status (27)

Country Link
US (1) US3982005A (fr)
JP (1) JPS60358B2 (fr)
AT (1) AT348140B (fr)
BE (1) BE832099R (fr)
BG (3) BG25090A3 (fr)
CA (1) CA1049008A (fr)
CH (7) CH613963A5 (fr)
CS (1) CS189717B2 (fr)
DD (1) DD122685A5 (fr)
DE (1) DE2437610A1 (fr)
DK (1) DK138992C (fr)
ES (6) ES452766A1 (fr)
FI (1) FI63229C (fr)
FR (1) FR2320096A2 (fr)
GB (1) GB1513950A (fr)
HU (1) HU177952B (fr)
IE (1) IE42216B1 (fr)
IL (1) IL47860A (fr)
LU (1) LU73138A1 (fr)
NL (1) NL7509249A (fr)
NO (1) NO143460C (fr)
PH (1) PH13687A (fr)
PL (3) PL99819B1 (fr)
RO (3) RO67390A (fr)
SE (1) SE425392B (fr)
SU (3) SU591147A3 (fr)
ZA (1) ZA754997B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
CL2008002199A1 (es) 2007-07-26 2009-10-23 Vitae Pharmaceuticals Inc Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
AR069545A1 (es) 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の環状尿素阻害剤
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (fr) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Carbazate cyclique et inhibiteurs du type semi-carbazide de la 11 -hydroxystéroïde déshydrogénase 1
EP2254872A2 (fr) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Inhibiteurs de 11beta-hydroxystéroïde deshydrogénase 1
CA2723034A1 (fr) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
BRPI0911764A2 (pt) 2008-05-01 2015-10-06 Boehringer Ingelheim Int inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
AR071719A1 (es) 2008-05-13 2010-07-07 Boehringer Ingelheim Int Derivados aliciclicos de acido carboxilico de benzomorfanos y estructuras relacionadas, medicamentos que contienen dichos compuestos y su uso.procesos de obtencion
US8114868B2 (en) 2008-07-25 2012-02-14 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
AR078887A1 (es) * 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
EP2582698B1 (fr) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Hétérocycles à 5, 6 et 7 chaînons substitués, médicaments contenant ces composés et leur utilisation
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体
EP4253494A1 (fr) 2020-11-26 2023-10-04 Shin-Etsu Chemical Co., Ltd. Composition d'organopolysiloxane durcissable à température ambiante, article, composé organosilane hydrolysable et son procédé de production
WO2023032745A1 (fr) 2021-09-03 2023-03-09 信越化学工業株式会社 Composé organopolysiloxane, composition d'organopolysiloxane durcissable à température ambiante et article

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (fr) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166804B2 (fr) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CS189717B2 (en) 1979-04-30
PL99816B1 (pl) 1978-08-31
DD122685A5 (fr) 1976-10-20
ES452764A1 (es) 1977-10-16
LU73138A1 (fr) 1977-04-13
RO72735A (fr) 1982-09-09
RO72736A (fr) 1982-09-09
ES452765A1 (es) 1977-10-16
GB1513950A (en) 1978-06-14
CA1049008A (fr) 1979-02-20
BG25090A3 (en) 1978-07-12
NO143460B (no) 1980-11-10
NO752731L (fr) 1976-02-06
SU591147A3 (ru) 1978-01-30
PL99819B1 (pl) 1978-08-31
CH613963A5 (fr) 1979-10-31
FR2320096B2 (fr) 1978-09-01
BE832099R (fr) 1976-02-04
FI63229B (fi) 1983-01-31
BG25089A3 (en) 1978-07-12
FR2320096A2 (fr) 1977-03-04
CH616420A5 (fr) 1980-03-31
CH615678A5 (fr) 1980-02-15
AU8364675A (en) 1977-02-10
CH615677A5 (fr) 1980-02-15
ES452763A1 (es) 1977-10-01
SE7508789L (sv) 1976-02-10
DK352875A (da) 1976-02-06
IE42216B1 (en) 1980-07-02
PL99838B1 (pl) 1978-08-31
NO143460C (no) 1981-02-18
ES452766A1 (es) 1977-10-01
ZA754997B (en) 1977-04-27
DK138992C (da) 1979-04-30
SU587859A3 (ru) 1978-01-05
JPS5139673A (en) 1976-04-02
SU587858A3 (ru) 1978-01-05
IL47860A0 (en) 1975-11-25
BG25088A3 (en) 1978-07-12
AT348140B (de) 1979-01-25
ES452768A1 (es) 1977-10-01
IE42216L (en) 1976-02-05
JPS60358B2 (ja) 1985-01-07
SE425392B (sv) 1982-09-27
DK138992B (da) 1978-11-27
CH615679A5 (fr) 1980-02-15
DE2437610A1 (de) 1976-02-26
ES452767A1 (es) 1977-10-01
CH616421A5 (fr) 1980-03-31
PH13687A (en) 1980-09-01
RO67390A (fr) 1981-06-30
US3982005A (en) 1976-09-21
CH615680A5 (fr) 1980-02-15
IL47860A (en) 1979-01-31
HU177952B (en) 1982-02-28
NL7509249A (nl) 1976-02-09
FI63229C (fi) 1983-05-10
ATA523775A (de) 1978-06-15

Similar Documents

Publication Publication Date Title
FR2320096B2 (fr)
FI750652A (fr)
FR2287996B1 (fr)
FR2288027B1 (fr)
FR2259397B1 (fr)
FR2299326B1 (fr)
AU495028B2 (fr)
IN145117B (fr)
BG20941A1 (fr)
BG20230A1 (fr)
BG21526A1 (fr)
CH363074A4 (fr)
BG21508A1 (fr)
BG21503A1 (fr)
BG21451A1 (fr)
BG21271A1 (fr)
BG21161A1 (fr)
BG21143A1 (fr)
BG21132A1 (fr)
BG21122A1 (fr)
BG21080A1 (fr)
BG21745A1 (fr)
BG20866A1 (fr)
BG20685A1 (fr)
BG20476A1 (fr)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: C.H. BOEHRINGER SOHN